Tiberend provides expert communications counsel that empowers our clients to achieve their business goals.
Tiberend has broad expertise across multiple sectors and therapeutic areas.
Tiberend’s mission is to be an integral component of our clients’ business activities.
Tiberend develops investor relations strategies that enable companies to meet their capital markets’ needs.
Tiberend Strategic Advisors is focused exclusively on the life sciences industry. We specialize in creating and executing “high touch” strategic investor and public relations programs to communicate a company’s value proposition to the audiences that have the greatest influence on their growth and success — investors, industry stakeholders, patients, healthcare practitioners, and the media.
Tiberend’s expertise is built upon a foundation of deep industry knowledge, scientific acumen, well-cultivated contacts, and a passion for getting the job done. We analyze each client situation and develop action plans that reflect near-term and longer-range opportunities specific to each client’s anticipated growth trajectory.
Tiberend offers a full suite of investor and public relations services, spanning all disciplines that our clients require. Our ability to seamlessly integrate investor and public relations, in addition to product communications, clinical trial recruitment and social media, into a cohesive program, and then execute on each opportunity with maximum return, is, we believe, unrivaled by other agencies.
Tiberend is comprised of senior level staff members with multiple years’ experience in healthcare investor communications. All of our clients benefit from having account teams comprised of individuals who are seasoned and knowledgeable in the space. LEARN MORE about our individual team members.
Gregory Q. Tiberend
President & CEO
EVP & COO
EVP, Investor Relations
VP, Investor Relations